Literature DB >> 19009348

Helicobacter pylori infection as a risk factor for insulin resistance.

Ahad Eshraghian1, Seyed Ali Hashemi, Alireza Hamidian Jahromi, Hamed Eshraghian, Seyed Masoum Masoompour, Mohamad Ali Davarpanah, Kavus Eshraghian, Seyed Alireza Taghavi.   

Abstract

This study aimed to determine the relation between Helicobacter pylori infection and insulin resistance in healthy subjects. In a cross-sectional case control study between January and April 2007, a total of 71 healthy subjects without the exclusion criteria completed the study. Forty-three (60.6%) patients were H. pylori positive and 28 (39.4%) patients were H. pylori negative. Age and body mass index of the patients were not significantly different between the two groups (32.2 +/- 14.2 vs. 33 +/- 8.05 years and 23.15 +/- 4.5 vs. 24.04 +/- 3.2 kg/m(2), respectively). H-pylori-positive patients had significantly higher HOMA-IR level compared to H-pylori-negative patients (3.54 +/- 2.2 vs. 2.46 +/- 1.9, respectively) (P < 0.05). Fasting serum insulin level was significantly higher in the H-pylori-positive group compared with the H-pylori-negative group (19.41 +/- 3.08 vs. 16.57 +/- 2.02 microU/ml, respectively) (P < 0.05). Our findings suggest recognition of H. pylori infection as a risk factor for insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19009348     DOI: 10.1007/s10620-008-0557-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Smoking and incidence of diabetes among U.S. adults: findings from the Insulin Resistance Atherosclerosis Study.

Authors:  Capri Gabrielle Foy; Ronny A Bell; Deborah F Farmer; David C Goff; Lynne E Wagenknecht
Journal:  Diabetes Care       Date:  2005-10       Impact factor: 19.112

Review 3.  Insulin resistance--mechanisms, syndromes, and implications.

Authors:  D E Moller; J S Flier
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

4.  Burden of infection and insulin resistance in healthy middle-aged men.

Authors:  José-Manuel Fernández-Real; Abel López-Bermejo; Joan Vendrell; Maria-José Ferri; Mónica Recasens; Wifredo Ricart
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

5.  How obesity causes diabetes: not a tall tale.

Authors:  Mitchell A Lazar
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

6.  Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial.

Authors:  Peter Wiesli; Wolfgang Czerwenka; Alfredo Meniconi; Friedrich E Maly; Ulrich Hoffmann; Wilhelm Vetter; Georg Schulthess
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

7.  Serum leptin level in patients with functional dyspepsia.

Authors:  K B Lankarani; M Moghadami; M Masoumpoor; B Geramizadeh; G R Omrani
Journal:  Dig Liver Dis       Date:  2004-11       Impact factor: 4.088

8.  Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.

Authors:  T J Colturi; R H Unger; M Feldman
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.

Authors:  B Longo-Mbenza; J Nkondi Nsenga; D Vangu Ngoma
Journal:  Int J Cardiol       Date:  2007-03-26       Impact factor: 4.164

10.  Modulation of insulin activities by leptin.

Authors:  B Cohen; D Novick; M Rubinstein
Journal:  Science       Date:  1996-11-15       Impact factor: 47.728

View more
  30 in total

1.  Association of H. pylori infection with chronic kidney disease among Chinese adults.

Authors:  Xianglei Kong; Dayu Xu; Feng Li; Xiaojing Ma; Hong Su; Dongmei Xu
Journal:  Int Urol Nephrol       Date:  2017-01-02       Impact factor: 2.370

2.  Helicobacter pylori and insulin resistance: time to do interventional studies.

Authors:  Rinaldo Pellicano; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2009-09-30       Impact factor: 3.199

3.  H. pylori seroprevalence and risk of diabetes: An ancillary case-control study nested in the diabetes prevention program.

Authors:  Saud Alzahrani; Jason Nelson; Steven F Moss; Jessica K Paulus; William C Knowler; Anastassios G Pittas
Journal:  J Diabetes Complications       Date:  2017-06-03       Impact factor: 2.852

Review 4.  The occupational risk of Helicobacter pylori infection: a systematic review.

Authors:  Hassan Kheyre; Samantha Morais; Ana Ferro; Ana Rute Costa; Pedro Norton; Nuno Lunet; Bárbara Peleteiro
Journal:  Int Arch Occup Environ Health       Date:  2018-05-29       Impact factor: 3.015

Review 5.  The new puzzle about the treatment of type 2 diabetes after the ACCORD and Da Qing studies.

Authors:  Michael Pfeiffer; Rüdiger von Bauer; Peter P Nawroth
Journal:  Langenbecks Arch Surg       Date:  2011-03-30       Impact factor: 3.445

6.  Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway.

Authors:  Xiaoying Zhou; Wei Liu; Min Gu; Hongwen Zhou; Guoxin Zhang
Journal:  J Gastroenterol       Date:  2015-02-19       Impact factor: 7.527

Review 7.  Extraintestinal manifestations of Helicobacter pylori: a concise review.

Authors:  Frank Wong; Erin Rayner-Hartley; Michael F Byrne
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 8.  Helicobacter pylori infection and diabetes: is it a myth or fact?

Authors:  Cong He; Zhen Yang; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

Review 9.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

10.  Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease.

Authors:  Myong Ki Baeg; Seung Kew Yoon; Sun-Hye Ko; Yong-Sun Noh; In-Seok Lee; Myung-Gyu Choi
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.